Money Today Reporter Heo Nam-i | 2024.04.25 20:29
JD Life Science (CEO Kim Hae-young) won the grand prize in the technology innovation (bio) category at the Money Today ‘2024 Korea Innovation Awards’ held at the Press Center in Jung-gu, Seoul on the 25th.
JD Life Science CEO Kim Hae-young (right) is taking a commemorative photo with Money Today Executive Director Song Ki-yong (left) after winning the ‘2024 Korea Innovation Award’.
The ‘Korea Innovation Awards’ is an award established to select, praise and encourage outstanding companies that have grown through consistent innovation and created new value in various fields such as technology, products, management, and services.
JD Life Science is a company with original patent technology that activates human microcurrent and adjusts acidified blood and body fluids to slightly alkaline using Somatide biomaterial and EZ Water.
Recently, as interest in reverse aging and anti-aging has focused, life science experts and companies around the world are actively developing technologies aimed at extending lifespan and regenerating cells against reverse aging.
In line with this trend, JD Life Science developed the patented Somatid technology, which prevents the accumulation of toxins in the body, which are the cause of human diseases and chronic diseases, acidification of human blood and body fluids, and positronization of bioelectricity (MMP) in the human body, inactivation of blood circulation and metabolism. He said he was focused on stabilizing the situation.
When you take a hot bath in EZ Water (H₃O₂), whose structure has been changed to Somatide bio material, the negative electrons, alkali, and oxygen of EZ Water’s hot water act to help with cell regeneration and health recovery in patients with chronic diseases.
JD Life Science operates the Somatide EZ Water Natural Healing Healing Center in Pyeongchang, Gangwon-do, helping users with their health and healing and developing innovative natural healing technologies.
CEO Kim Hae-young said, “We plan to launch health functional foods, functional cosmetics, and pressure ulcer treatment products based on Somatid’s patented technology within this year,” adding, “We will grow into a bio company that contributes to extending the lifespan and improving the health of consumers in Korea and around the world.” “We will focus more on research and technology development for this purpose,” he said.
[저작권자 @머니투데이, 무단전재 및 재배포 금지]
